EQ Company Profile and Key Details
Equillium, Inc.
EQ Stock Price Chart
Stock Price Today
Equillium, Inc. (EQ) stock declined over -4.67%, trading at $0.61 on NASDAQ, down from the previous close of $0.64. The stock opened at $0.62, fluctuating between $0.61 and $0.64 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which is in Phase III clinical trials for the treatment of acute graft-versus-host disease; completed Phase Ib clinical trial for the treatment of asthma disease; and Phase Ib clinical trial for the treatment of and lupus nephritis. It also develops EQ101 for treatment of cutaneous T cell lymphoma and alopecia areata; and EQ102 to treat various gastrointestinal diseases. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California.
Company Information
| Employees | 45 |
| Beta | 1.83 |
| Sales or Revenue | $36.08M |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Equillium, Inc. (NASDAQ: EQ) stock price is $0.61 in the last trading session. During the trading session, EQ stock reached the peak price of $0.64 while $0.61 was the lowest point it dropped to. The percentage change in EQ stock occurred in the recent session was -4.67% while the dollar amount for the price change in EQ stock was -$0.03.
The NASDAQ listed EQ is part of Biotechnology industry that operates in the broader Healthcare sector. Equillium, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Ms. Maple Fung M.D.
Chief Medical Officer
Dr. Stephen Connelly Ph.D.
Chief Scientific Officer & Director
Mr. Jason A. Keyes
Chief Financial Officer
Dr. Krishna R. Polu M.D.
Consultant
Mr. Daniel Mark Bradbury
Executive Chairman
Matthew Ritter Ph.D.
Senior Vice President of Corporation Devel.
Mr. Bruce D. Steel C.F.A.
Co-Founder, Pres, Chief Executive Officer & Director
Ms. Christine Zedelmayer M.B.A., P.M.P.
Senior Vice President & Chief Operating Officer
Mr. Joel M. Rothman
Chief Devel. Officer
EQ's closing price is 28.02% higher than its 52-week low of $0.49 where as its distance from 52-week high of $3.25 is -80.31%.
Number of EQ employees currently stands at 45.
Official Website of EQ is: https://equilliumbio.com
EQ could be contacted at phone 858 412 5302 and can also be accessed through its website. EQ operates from 2223 Avenida De La Playa, La Jolla, CA 92037, United States.
EQ stock volume for the day was 62.59K shares. The average number of EQ shares traded daily for last 3 months was 185.11K.
The market value of EQ currently stands at $21.62M with its latest stock price at $0.61 and 35.43M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com